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Abstract Pho85p is a yeast cyclin-dependent protein kinase
(Cdk) that can interact with 10 cyclins (Pcls) to form multiple
protein kinases. The functions of most of the Pcls, including
Pc16p and Pc17p, are poorly defined. We report here that Pc16p
and Pc17p are involved in the metabolism of the branched
storage polysaccharide glycogen under certain conditions and
deletion of PCL6 and PCL7 restores glycogen accumulation to a
snf1 pcl8 pcl10 triple mutant, paradoxically activating both
glycogen synthase and phosphorylase. Pho85p thus affects
glycogen accumulation through multiple Cdks composed of
different cyclin partners. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Cyclin-dependent protein kinases (Cdks) are hetero-dimeric
enzymes that contain a kinase catalytic subunit associated
with a regulatory cyclin partner (reviewed in [1]). These en-
zymes were ¢rst identi¢ed because of their roles in cell cycle
progression and the cyclins were named because their levels
£uctuated during the course of cell division [1^3]. Pho85p, one
of ¢ve Cdks in the budding yeast Saccharomyces cerevisiae,
appears to have pleiotropic functions [4] presumably due to its
ability to interact with 10 di¡erent Pho85 cyclins or Pcls [5^7].
The Pcls have been placed into two groups, one (composed of
Pcl1p, Pcl2p, Pcl5p, Pcl9p and Clg1p) postulated to function
in cell cycle controls and the other (Pho80p, Pcl6p, Pcl7p,
Pcl8p and Pcl10p) in metabolic regulation [8]. Pho80p is im-
plicated in the control of gene expression in response to lim-
itation of inorganic phosphate [9^11]. Pcl1p, Pcl2p and Pcl9p
are thought to have roles in controlling cell cycle progression
[6,12,13] and Pcl1p/Pho85p phosphorylates the Cdk inhibitor
Sic1p in vitro [14]. Pcl9p and Pcl2p interact with Rvs167p
providing a possible link between cell cycle controls and the
actin cytoskeleton [15]. Pcl8p and Pcl10p have been implicated
in the regulation of glycogen accumulation, and Pcl10p has
been shown to be a targeting subunit that directs Pho85p to
phosphorylate Gsy2p, the major glycogen synthase isoform in
yeast [16,17]. Glycogen is a major polysaccharide storage form
of glucose whose synthesis and utilization are intricately con-
trolled by nutritional status [18,19]. Very little is known of the
functions of Pcl6p and Pcl7p. Lee et al. [20] have shown that a
Pcl7p/Pho85p complex has protein kinase activity and also
that PCL7 expression £uctuates during the cell cycle, with a
maximum in mid to late S phase. Some defects in carbon
source utilization were also reported.
SNFl encodes the yeast homologue of the mammalian
AMP-activated protein kinase and has been studied exten-
sively for its regulation of the expression of glucose-repressed
genes (reviewed in [21^23]). In addition, sn£ mutants do not
accumulate glycogen, but this defect appeared to be linked to
hyperphosphorylation, and inactivation, of glycogen synthase
rather than the modest, two-fold reduction in enzyme level
that was observed [24]. Thus, we used a sn£ mutant to screen
for second site suppressors of the glycogen defect with the
goal of identifying glycogen synthase kinases. This resulted
in our demonstration that Pho85p was a component of a
glycogen synthase kinase [25]. We went on to establish that
Pcl8p and Pcl10p directed Pho85p to the control of glycogen
synthase phosphorylation [16]. However, when we examined
sn£ pcl8 pcl10 mutants, we unexpectedly found that this
strain, unlike sn£ pho85 double mutants, failed to store gly-
cogen.
2. Materials and methods
2.1. Strains, media and genetic methods
The S. cerevisiae strains used are listed in Table 1. Rich medium
contains 1% (w/v) yeast extract, 2% (w/v) Bacto peptone, and 2%
(w/v) of the indicated carbon source (glucose in YPD medium). Syn-
thetic complete medium contains 0.67% (w/v) yeast nitrogen base, 2%
(w/v) of the indicated carbon source (glucose in SD) and complete
supplement mix (Bio 101 Inc.). Synthetic selective medium consists of
0.67% (w/v) yeast nitrogen base, 2% (w/v) of the indicated carbon
source (glucose in SD) and the indicated complete supplement mix
lacking appropriate amino acids. For analysis of glycogen accumula-
tion on plates, aliquots (5^10 Wl) were spotted onto plates and cells
were grown for the indicated time before detection of glycogen by
exposing plates to iodine vapor. Plasmids were maintained in Esche-
richia coli DH5K. Standard methods of yeast genetic analysis and
transformation were used [26]. To generate sn£ pcl8 pcl10 pcl6 pcl7
mutant cells, strain ZWS2 was crossed with DH106-91. The diploid
cells were then sporulated and tetrads were analyzed. Null mutants
were scored according to the marker genes TRPl or URA3, and the
null mutants were further conformed by PCR.
2.2. Plasmids
The PCL6 and PCL7 coding sequences were ampli¢ed by PCR
from yeast genomic DNA and cloned into the TA vector (Invitrogen).
To generate PCL6 with an NH2-terminal Flag tag, the following
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primers, 5P-TCCCGGGGGAATTCatgGACTACAAAGACGATGA-
CGACAAGtctacaaaggtgattccccc and 3P-ACTCGAGctacatgcccgtaac-
tag, were used to add an EcoRI site, the tag and a XhoI site (upper
case). To generate PCL7 with an NH2-terminal Flag tag, the follow-
ing primers, 5P-TGGATCCatgGACTACAAAGACGATGACGAC-
AAGgagctaagttcaccatcaaaaaaaacc and 3P-TCTCGAGctactggtcgttcca-
gaattt, were used to add a BamHI site, the tag and a XhoI site (upper
case). The PCR product was cloned into the pPCR2.1 vector and
checked by sequencing. An EcoRI/XhoI fragment containing the
PCL6 open reading frame was cloned into the p425-TEF vector be-
tween the EcoRI and XhoI sites. A BamHI/XhoI fragment containing
PCL7 was cloned into the p425-TEF vector between the BamHI and
XhoI sites.
2.3. Enzyme and other assays
For the assay of glycogen synthase and glycogen phosphorylase
activity in yeast cell extracts, cultures were grown in 150 ml of the
indicated medium in 500 ml £asks at 30‡C. Aliquots of 7 ml were
removed at the indicated time points, and cells were harvested by
centrifugation (2 min, room temperature, 1500Ug) in a clinical
bench-top centrifuge. The cell pellet was frozen on dry ice and stored
at 380‡C prior to analysis. The frozen cells were thawed on ice and
resuspended in 400 Wl homogenization bu¡er (50 mM Tris^HCl, 1 mM
EDTA, 5 mM dithiothreitol, 50 mM NaF, 1 mM phenylmethylsul-
fonyl £uoride, 0.1 mM NK-p-tosyl-L-lysine chloromethyl ketone, 5 mM
benzamidine, 0.25 Wg/ml leupeptin, and 0.5 Wg/ml aprotinin, pH 7.4).
The cells were broken with glass beads as described previously [24].
Glycogen synthase was assayed by the method of Thomas et al.
[27], as described by Hardy et al. [24]. The total activity of glycogen
synthase is measured in the presence of 7.2 mM glucose-6-P. The 3/+
glucose-6-P activity ratio is de¢ned as the activity measured in the
absence of glucose-6-P divided by the activity measured in its pres-
ence. Each measurement was the average of duplicate assays.
Glycogen phosphorylase was assayed in the direction of glycogen
synthesis by published methods with minor modi¢cation [28,29]. Each
measurement was the average of duplicate assays.
2.4. Measurement of glycogen, ATP and glucose-6-P
Quantitative determination of glycogen content of yeast cells was
performed as described previously [30]. Aliquots (V1^2U107 cells) of
cells grown in SD-Leu medium to stationary phase were used to in-
oculate fresh SD-Leu liquid medium. Aliquots of culture were col-
lected at the indicated time points and glycogen content was deter-
mined.
For measurement of ATP and glucose-6-P, yeast cells were grown
for the indicated times and harvested by rapid ¢ltration. Cells were
rapidly frozen in liquid nitrogen and stored at 380‡C until measure-
ment. The assay of glucose-6-P and ATP was carried out as described
[31].
3. Results
3.1. Deletion of PCL6 and PCL7 restores glycogen
accumulation to a snf1 pcl6 pcl8 mutant
Glycogen accumulation is conveniently assessed by staining
colonies grown on plates with iodine vapor, darker staining
correlating with increased glycogen levels (Fig. 1). The lack of
glycogen storage in snf1 mutants, noted in Section 1, and its
restoration by the additional deletion of PHO85 are also
shown. However, snf1 pcl8 pcl10 triple mutants did not accu-
mulate glycogen under these conditions (Fig. 1). Therefore,
PHO85 exerts an in£uence over glycogen accumulation that
is independent of PCL8 and PCL10 but presumably mediated
by other Pho85p cyclins. Reasoning that the responsible Pcls
would belong to the so-called metabolic group, we con-
structed the mutant snf1 pcl6 pcl7 pcl8 pcl10 and analyzed
glycogen accumulation. This quintuple mutant accumulated
glycogen (Fig. 1). The rationale for mutating both PCL6
and PCL7 was based on the fact that these two Pcls are
more closely related to each other than other Pcls and may
constitute a gene pair with functional overlap. Indeed, the
quadruple mutants, snf1 pcl6 pcl8 pcl10 and snf1 pcl7 pcl8
pcl10, had somewhat lower glycogen accumulation and the
increased accumulation in the quintuple mutant was di⁄cult
to assign to loss of either gene individually (data not shown).
Mutation of PCL6 and PCL7, in a wild-type (not shown) or a
snf1 (Fig. 1) background, also did not elevate glycogen levels.
Therefore, Pho85p kinases containing both Pcl8/10p and Pcl6/
7p are necessary to permit glycogen accumulation in the ab-
sence of Snf1p.
3.2. Deletion of PCL6 and PCL7 activates glycogen synthase
and phosphorylase
In order to explore the mechanism by which Pcl6/7 a¡ects
glycogen accumulation, the activities of the synthetic and deg-
Table 1
Yeast trains used in this study
Strain Genotype Reference or source
DH106-91 MAT a trp1 leu2 ura3-52 pcl6: :URA3 pcl7: :TRP1 This laboratory
DH29 MAT K trp1 leu2 ura3-52 snf1: :LEUu2 pho85: :URA3 This laboratory
EG328-1A MAT K trp1 leu2 ura3-52 K. Tatchell
EG353-1C MAT K trp1 leu2 ura3-52 snf1: :URA3 K. Tatchell
ZWS2 MAT K trp1 leu2 ura3-52 snf1: :TRP1 pcl8: :URA3 pcl10: :URA3 This laboratory
ZW33-54 MAT K trp1 leu2 ura3-52 snf1: :TRP1 pcl8: :URA3 pcl10: :URA3 pcl6: :URA3 pcl7: :TRP1 This laboratory
ZW32-1 MAT K trp1 leu2 ura3-52 snf1: :TRP1 pcl6: :URA3 pcl7: :TRP1 This laboratory
All strains are isogenic to EG328-1A.
Fig. 1. Glycogen accumulation by various snf1 and pcl mutants.
Strains were grown for 48 h on SC plates and glycogen accumula-
tion assessed by exposure to iodine vapor for 2 min. Strains used:
wild-type (EG328-1A), snf1 (EG353-1C), snf1 pho85 (DH29), snf1
pcl6 pcl7 (ZW32-1), snf1 pcl8 pcl10 (ZWS2), sfn1 pcl6 pcl7 pcl8
pcl10 (ZW33-54).
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radative enzymes were analyzed in snf1 pcl8 pcl10 and snf1
pcl6 pcl7 pcl8 pcl10 strains. Glycogen phosphorylase, the en-
zyme primarily responsible for glycogen degradation, was ac-
tually increased (Fig. 2) in the strain lacking PCL6 and PCL7,
which would simplistically be expected to correlate with de-
creased glycogen accumulation. However, the two strains also
di¡ered in the level of the biosynthetic enzyme and total gly-
cogen synthase activity was two-fold higher at 24^30 h and
¢ve-fold at 48 h. The activation state of the glycogen synthase,
which is determined by its phosphorylation state, was rela-
tively constant over this period. We conclude therefore that
the balance of the e¡ects on glycogen synthase and phosphor-
ylase was in favor of synthesis, especially at the later times.
Glucose-6-P concentration, which can a¡ect both phosphor-
ylase and glycogen synthase, was not di¡erent between the
two strains (data not shown).
3.3. PCL6 and PCL7 overexpression reduces
glycogen accumulation
Either PCL6 or PCL7 was overexpressed in a snf1 pcl6 pcl7
pcl8 pcl10 mutant strain from a high copy plasmid p425-TEF
[32] under control of the TEF promoter (Fig. 3). Compared to
a control with empty vector, the expression of either PCL6
or PCL7 signi¢cantly diminished glycogen levels and this
was sustained late into stationary phase. In addition, the re-
sult was similar whether PCL6 or PCL7 was expressed, sug-
gesting that both have similar roles as relates to glycogen
metabolism.
4. Discussion
The cellular functions of Pcl6/7p are poorly understood and
an immediate outcome of this study is to establish a link
between PCL6 and PCL7 and glycogen accumulation. Such
a relationship had been suggested in the study of Lee et al.
[20] who reported, however, that disruption of PCL6 and
PCL7 in a wild-type background resulted in a reduced glyco-
gen level. In our experiments, a pcl6 pcl7 mutant had normal
glycogen accumulation whereas deletion of PCL6 and PCL7
in a snf1 pcl8 pcl10 background had the opposite e¡ect, re-
storing glycogen storage. The present study also sheds light on
this apparent discrepancy. Pho85p appears to be involved in a
complex regulation of di¡erent steps of glycogen metabolism,
not all of which are conceptually coherent (Fig. 4). For exam-
ple, via control of the activities of glycogen synthase and
phosphorylase, there are negative inputs both to glycogen syn-
Fig. 2. Glycogen phosphorylase and glycogen synthase activity in
snf1 pcl6 pcl7 and snf1 pcl6 pcl7 pcl8 pcl10. Strains were grown in
SC medium. At the indicated times, samples were withdrawn and
glycogen phosphorylase (A) and glycogen synthase (B) activities de-
termined. Strains used: snf1 pcl8 pcl10 (ZWS2, solid bar), snf1 pcl6
pcl7 pcl8 pcl10 (ZW33-54, hatched bar).
Fig. 3. Overexpression of Pcl6p or Pcl7p in snf1 pcl8 pcl10 pcl6 pcl7
mutant cells decreases glycogen accumulation. snf1 pcl8 pcl10 pcl6
pcl7 mutants (ZW33-54) harboring di¡erent plasmids (p425-TEF,
b ; p425-TEF-PCL6, E ; or p425-TEF-PCL7, a) were grown in SD-
Leu medium. At the indicated times, samples were withdrawn and
glycogen content was measured. The data are the average from two
independent transformants.
Fig. 4. Multiple inputs of Pho85p into the regulation of glycogen
accumulation. The Pho85p kinase regulates glycogen storage both
positively and negatively via interaction with di¡erent cyclin sub-
units. In conjunction with the cyclins Pcl8p and Pcl10p, Pho85p
phosphorylates and inactivates glycogen synthase, leading to a re-
duction in glycogen stores. The complex of Pho85p and Pcl6/7p in-
activates glycogen phosphorylase and negatively regulates the level
of glycogen synthase. Arrows indicate positive regulation, bars indi-
cate negative regulation.
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thesis and glycogen breakdown. This is reminiscent of cyclic
AMP-mediated control of gene expression whereby both gly-
cogen synthase and phosphorylase are induced as cells ap-
proach stationary phase [24,29,33,34]. Presumably, other sig-
nals must normally be layered over PHO85 control of
glycogen synthesis and degradation. These signals may in
turn depend on factors like growth conditions or genetic back-
ground. Such considerations may underlie the observation
that in our usual strain background, deletion of PHO85
causes much greater glycogen hyperaccumulation in cells
grown on rich medium than synthetic medium. In addition,
the genetic background may in£uence the consequences of
PHO85 mutation. For example, PHO85 deletion restores nor-
mal glycogen levels to snf1 mutants whether grown in YPD or
SC. The same assessment may extend to less well de¢ned
genetic di¡erences between strains. Disruption of PHO85 in
some strain backgrounds, such as NBD85A-1 from the col-
lection of the Brown laboratory, does not cause glycogen
hyperaccumulation (Fujino and Roach, unpublished results).
Likewise, Goding and colleagues reported that elimination of
PHO85 does not a¡ect glycogen storage in a W303 strain
whereas isogenic pcl6 or pcl7 mutants hypoaccumulated gly-
cogen [20]. When a single gene product is a constituent of
multiple regulatory enzymes that have opposing e¡ects on a
process of interest, the consequences of its deletion are hard to
predict and of necessity depend on other controls and condi-
tions.
We recently found that autophagy, which is a process
whereby cytosol and organelles are delivered to the vacuole
for recycling, is a determinant of glycogen accumulation in
yeast and is under the control of SNF1 and PHO85 [30].
Defective autophagy correlates with the inability to maintain
glycogen and, although this occurred without e¡ects on the
activities of glycogen synthase and phosphorylase, we wanted
to test whether PCL6 and PCL7 were connected indirectly
with glycogen accumulation through a role in controlling au-
tophagy. We analyzed autophagy in a pcl6 pcl7 double mutant
and found normal induction as the cells entered into station-
ary phase (Wang and Roach, unpublished results). Therefore,
the e¡ects of PCL6 and PCL7 are likely mediated by changes
in metabolic enzymes, although the exact mechanism remains
to be determined.
Pho85p and its associated Pcls are an example of an enzyme
family in which a common catalytic subunit is utilized in
multiple functionally distinct complexes. It is important in
considering such enzyme systems to recognize that the func-
tional identity of the enzyme complex is conferred by the
regulatory component(s), the Pcl for Pho85p kinases, which
can be subject to its own speci¢c controls. We have previously
proposed a model in which an excess of free Pho85p forms a
reservoir from which individual Pcl/Pho85p kinases are
formed as needed [17]. Although a global control, through
the Pho85p catalytic subunit, is formally possible, this seems
not to be true since Pho85p is not regulated by phosphoryla-
tion and its level is relatively constant under a variety of
conditions [17,35]. The present study re-emphasizes the need
to view each Pcl/Pho85p as a distinct entity and brings the
added complexity that di¡erent Pcl/Pho85p kinases can exert
opposing controls over the same process.
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